| Satellite image segmentation for building detection using U-Net G Chhor, CB Aramburu, I Bougdal-Lambert Web: http://cs229. stanford. edu/proj2017/final-reports/5243715. pdf, 2017 | 46 | 2017 |
| Artificial intelligence and dermatology: opportunities, challenges, and future directions. DI Schlessinger, G Chhor, O Gevaert, SM Swetter, J Ko, RA Novoa Seminars in cutaneous medicine and surgery 38 (1), E31-37, 2019 | 35 | 2019 |
| Digital pathology based prognostic & predictive biomarkers in metastatic non-small cell lung cancer A Qamra, MK Srivastava, E Fuentes, B Trotter, R Biju, G Chhor, J Cowan, ... Cancer Research 83 (7_Supplement), 5705-5705, 2023 | 1 | 2023 |
| Abstract PO-072: Robust deployment of ML models quantifying the H&E tumor microenvironment in NSCLC subjects from an AstraZeneca-sponsored phase II clinical trial B Glass, L Dillon, G Chhor, S Hoffman, V Chinnaobireddy, SC Gullapally, ... Clinical Cancer Research 27 (5_Supplement), PO-072-PO-072, 2021 | 1 | 2021 |
| Robust deep reinforcement learning for autonomous driving G Chhor, S Pandey, V Patel | 1 | 2018 |
| P1246: CELL TYPE IDENTIFICATION USING MULTIPLEX IMMUNOFLUORESCENCE (MIF) GUIDED MACHINE LEARNING IN DLBCL G Chhor, S Vilchez, P Chang, T Novitskaya, C Hedvat, L Yu, M Resnick, ... HemaSphere 7 (S3), e7646597, 2023 | | 2023 |
| Development of a high-throughput image processing pipeline for multiplex immunofluorescence whole slide images at scale W Tahir, E Krause, J Li, H Mak, M Mirzadeh, K Rose, J Shen, V Valaboju, ... Cancer Research 83 (7_Supplement), 6616-6616, 2023 | | 2023 |
| Abstract CT112: AI-powered and manual assessment of PD-L1 are comparable in predicting response to neoadjuvant atezolizumab in patients (pts) with resectable non-squamous, non … J Abel, C Rivard, F Kos, G Chhor, Y Liu, J Giltnane, S Hoffman, M Resnick, ... Cancer Research 82 (12_Supplement), CT112-CT112, 2022 | | 2022 |
| Abstract LB016: Deep learning identifies pathobiological features within H&E images associated with genomic alterations and progression on anti-PD (L) 1 in HUDSON, an … L Dillon, M Hernandez, B Glass, G Chhor, S Hoffman, V Chinnaobireddy, ... Cancer Research 81 (13_Supplement), LB016-LB016, 2021 | | 2021 |
| Robust deployment of ML models quantifying the H&E tumor microenvironment in NSCLC subjects from an AstraZeneca-sponsored phase II clinical trial B Glass, L Dillon, G Chhor, S Hoffman, V Chinnaobireddy, SC Gullapally, ... CLINICAL CANCER RESEARCH 27 (5), 2021 | | 2021 |
